Manufacturing Chemist Manufacturing Chemist
  • Home
  • Ingredients
  • Analysis
  • Manufacturing
  • Finance
  • Events
  • Directory
  • Regulatory
  • Drug Delivery
  • Research & Development
  • Sustainability

Ablynx nv

www.ablynx.com

Technologie Park 21
Ghent/Zwijnaarde
B-9052
Belgium

+32 9 262 00 00

Activities

Regulatory | Research & Development | Pharmaceutical

Related Companies

  • Copley Scientific
  • Icrom SRL
  • Nanoform
  • SGS Health Sciences
  • Starlab
  • NSF
  • PCI Pharma Services
  • EECO2
  • Piramal Pharma Solutions
  • Butterworth Laboratories
  • Hermes Pharma GmbH
  • Ecolab Life Sciences
  • Vectorbuilder Inc
  • Indena
  • Quotient Sciences
  • Asymchem
  • ProtaGene
  • Royal Society of Chemistry
  • Actylis – The Partner of Choice
  • ARC Pharma

Related Content

Sanofi completes acquisition of Ablynx
Sanofi completes acquisition of Ablynx
Sanofi to acquire Ablynx for €3.9 billion
Sanofi to acquire Ablynx for €3.9 billion
Ablynx appoints Dr Robert Friesen as Chief Scientific Officer
Ablynx appoints Dr Robert Friesen as Chief Scientific Officer
Ablynx announces board changes
Ablynx announces board changes
Ablynx appoints General Manager
Ablynx appoints General Manager
Ablynx appoints Markus Ewert as CBO
Ablynx appoints Markus Ewert as CBO
Novel Nanobody to begin clinical development in osteoarthritis
Novel Nanobody to begin clinical development in osteoarthritis
Ablynx acheives first milestone as part of collaboration with Novo Nordisk
Ablynx acheives first milestone as part of collaboration with Novo Nordisk
Ablynx raises €74.2m in share placement
Ablynx raises €74.2m in share placement
Ablynx to receive an €8m milestone payment as Boehringer Ingelheim starts a Phase I study with an anti-CX3CR1 nanobody
Ablynx to receive an €8m milestone payment as Boehringer Ingelheim starts a Phase I study with an anti-CX3CR1 nanobody
Dr Robert Zeldin takes over as Chief Medical Officer at Ablynx
Dr Robert Zeldin takes over as Chief Medical Officer at Ablynx
Ablynx to work with Novo Nordisk on nanobody drug discovery
Ablynx to work with Novo Nordisk on nanobody drug discovery
Future drug success is all in the delivery
Future drug success is all in the delivery
Ablynx enters €13m immuno-oncology collaboration expansion with Merck
Ablynx enters €13m immuno-oncology collaboration expansion with Merck
Ablynx and Taisho Pharmaceutical enter agreement to develop rheumatoid arthritis drug in Japan
Ablynx and Taisho Pharmaceutical enter agreement to develop rheumatoid arthritis drug in Japan
  • Advertise Subscribe
  • Terms & Conditions
  • Privacy Policy
  • Contact us at info@hpcimedia.com
Twitter LinkedIn RSS newsfeed
© HPCi Media Limited | Registered in England No. 6716035 | VAT GB 939828072 | a Claverley Group company